Latest Breaking News On - Interim findings from - Page 1 : comparemela.com

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA

SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present preliminary findings from the SPARTAN Study evaluating

United kingdomNaomi eichenbaumJula inrigNivi nehraTravere therapeutics incInternational symposium on iga nephropathyCorporate communicationsExchange commissionInternational symposiumIga nephropathyUnited kingdom national registryRare renal diseasesIncident patients with iga nephropathyFirst line therapyInterim findings fromClinical trial

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomNaomi eichenbaumNivi nehraJula inrigTravere therapeutics incInternational symposium on iga nephropathyExchange commissionCorporate communicationsPresent abstractsInternational symposiumIga nephropathyUnited kingdom national registryRare renal diseasesIncident patients with iga nephropathyFirst line therapyInterim findings from

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomNaomi eichenbaumNivi nehraJula inrigTravere therapeutics incExchange commissionInternational symposium on iga nephropathyCorporate communicationsTravere therapeuticsInternational symposiumIga nephropathyUnited kingdom national registryRare renal diseasesIncident patients with iga nephropathyFirst line therapyInterim findings from

Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)

SAN DIEGO, Sept. 26, 2023 Travere Therapeutics, Inc. today announced that the Company and its collaborators will present preliminary findings from the SPARTAN Study evaluating the potential.

United kingdomNivi nehraJula inrigNaomi eichenbaumInternational symposium on iga nephropathyTravere therapeutics incExchange commissionCorporate communicationsInternational symposiumIga nephropathyUnited kingdom national registryRare renal diseasesIncident patients with iga nephropathyFirst line therapyInterim findings fromClinical trial